Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2025 1
2026 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.
Geers D, Aguilar-Bretones M, Zaeck LM, Gill PA, Gonzalez-Lopez C, Handrejk K, Tan NH, den Hartog Y, Gommers L, Bogers S, Mykytyn AZ, Sablerolles RSG, Goorhuis A, Postma DF, Visser LG, Dalm VASH, Lafeber M, Kootstra NA, van Baarle D, Haagmans BL, Koopmans MPG, GeurtsvanKessel CH, van der Kuy PHM, van Nierop GP, van Zelm MC, de Vries RD. Geers D, et al. J Infect. 2026 Feb;92(2):106681. doi: 10.1016/j.jinf.2026.106681. Epub 2026 Jan 8. J Infect. 2026. PMID: 41519394 Free article.
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease.
Nesamari R, Crowther C, Chiveto DT, Pillay T, Kgagudi P, Shusha N, Manamela N, Steel HC, van der Mescht MA, Slingers N, Davids LA, Tshabalala K, Ueckermann V, Seocharan I, Reddy T, Richardson SI, Moyo-Gwete T, Abdullah F, Moore PL, Rossouw TM. Nesamari R, et al. J Infect. 2026 Feb;92(2):106676. doi: 10.1016/j.jinf.2026.106676. Epub 2026 Jan 7. J Infect. 2026. PMID: 41513147 Free article.
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform.
Volkman HR, de Munter L, Nguyen JL, Tran TMP, Mitratza M, Marques C, Choi L, Valluri S, Yang J, Antón A, Casas I, Conde-Sousa E, Drikite L, Grüner B, Icardi G, Ten Kate GL, Martin C, Mira-Iglesias A, Orrico-Sánchez A, Otero-Romero S, Rohde G, Jodar L, McLaughlin JM, Bollaerts K. Volkman HR, et al. PLoS One. 2026 Feb 11;21(2):e0342382. doi: 10.1371/journal.pone.0342382. eCollection 2026. PLoS One. 2026. PMID: 41671248 Free PMC article.
32 results